Read + Share
Amedeo Smart
Independent Medical Education
Lim S, Park CY, Jeong IK, Yoon JS, et al. Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naive type 2 diabetes: The EMPA-FIT study. J Diabetes Complications 2025;40:109214.PMID: 41223492
Email
LinkedIn
Privacy Policy